US PRE-MARKET MOVERS: GOOG, MSFT, CRWV, NBIS, IREN, FTNT, NOW, KLAC, CTSH, TMUS, EBAY, NCLH, CAT, MA, LLY, MRK, LITE, MRVL
ORIGINAL · NewsquawkUS PRE-MARKET MOVERS: GOOG, MSFT, CRWV, NBIS, IREN, FTNT, NOW, KLAC, CTSH, TMUS, EBAY, NCLH, CAT, MA, LLY, MRK, LITE, MRVLRead originalHide original
ES -0.4% NQ -1.3% RTY -0.2% GOOG -11.3%: Weak report; profit & rev. light & worsening negative FCF MSFT +1%: EPS, rev. & op. income topped w/ better-than-exp. guidance CRWV -7%, NBIS -7%, IREN -5.5%: MSFT's lower-than-exp. capex points to infrastructure partners taking longer to deliver capacity FTNT -28%: Product rev. short of exp. w/ FY services guide cut & next Q rev. guide way short of bull exp. NOW -19%: Underwhelming subs. rev. guide w/ a bookings & profit miss KLAC +2.7%: Headline metrics topped w/ strong next Q guidance CTSH -10.5%: Weak next Q rev. outlook TMUS +3.2%: Profit, rev. & postpaid subs. additions beat alongside strong FY guidance EBAY +6%: Solid headline nos. & GMV, alongside upbeat holiday-Q outlook NCLH +12%: Top & bottom line beat w/ upbeat FY profit view CAT -11%: Top line shy of exp. MA +3.2%: Q3 results beat LLY +4.5%: Headline metrics topped w/ strong drug sales breakdown & lifted FY rev. outlook MRK +2.3%: Topped Q3 exp. as Keytruda & Gardasil outperformed LITE +6%: MRVL (-12%) in advanced talks to acquire Co.
The pre-market item reported mixed index and stock moves, citing company results, guidance, infrastructure-capacity delays, and reported Marvell–Lumentum acquisition talks.
News detail
ES -0.4% NQ -1.3% RTY -0.2% GOOG -11.3%: Weak report; profit & rev. light & worsening negative FCF MSFT +1%: EPS, rev. & op. income topped w/ better-than-exp. guidance CRWV -7%, NBIS -7%, IREN -5.5%: MSFT's lower-than-exp. capex points to infrastructure partners taking longer to deliver capacity FTNT -28%: Product rev. short of exp. w/ FY services guide cut & next Q rev. guide way short of bull exp. NOW -19%: Underwhelming subs. rev. guide w/ a bookings & profit miss KLAC +2.7%: Headline metrics topped w/ strong next Q guidance CTSH -10.5%: Weak next Q rev. outlook TMUS +3.2%: Profit, rev. & postpaid subs. additions beat alongside strong FY guidance EBAY +6%: Solid headline nos. & GMV, alongside upbeat holiday-Q outlook NCLH +12%: Top & bottom line beat w/ upbeat FY profit view CAT -11%: Top line shy of exp. MA +3.2%: Q3 results beat LLY +4.5%: Headline metrics topped w/ strong drug sales breakdown & lifted FY rev. outlook MRK +2.3%: Topped Q3 exp. as Keytruda & Gardasil outperformed LITE +6%: MRVL (-12%) in advanced talks to acquire Co.
Related stocks
19 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
